3 months ago
CYTK
AnalystsGena WangGena Wang's Stock Forecasts
AnalystsGena Wang
Sectors:
Industries:
Analyst Ranking
Bottom 9%
#4792 out of 5235 analysts
Average Return
-1.22%
Win Rate
42%73 out of 173
Risk vs Reward
Poor
Good
Gena Wang's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Beam Therapeutics IncBEAM | +315.20% | $23.02 | $95.58 | 2020-03-02 - 2021-03-01 | Strong Buy |
Moderna IncMRNA | +260.41% | $59.10 | $213.00 | 2020-06-08 - 2021-06-08 | Strong Buy |
4d Molecular Therapeutics IncFDMT | +207.79% | $3.08 | $9.48 | 2025-05-09 - 2026-04-02 | Strong Buy |
Solid Biosciences IncSLDB | +170.40% | $2.77 | $7.49 | 2025-05-16 - 2026-04-02 | Strong Buy |
Biocryst Pharmaceuticals IncBCRX | +170.38% | $3.95 | $10.68 | 2020-05-05 - 2021-05-05 | Strong Buy |
Gena Wang Analyst Color
Get additional color on Gena Wang's coverage of popular stocks
5 months ago
BCRX
5 months ago
ALNY
5 months ago
BMRN
6 months ago
CLLS
2 years ago
VIR
2 years ago
SLDB
2 years ago
RGNX
2 years ago
SRPT
2 years ago
VRTX
2 years ago
LEGN
3 years ago
VRTX
3 years ago
LEGN
3 years ago
LEGN
Gena Wang's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Legend Biotech CorpLEGN | 8 | Strong Buy | $80.00 | +317.97% | Maintains | 2 months ago |
Cytokinetics IncCYTK | 6 | Strong Buy | $87.00 | +30.38% | Assumes | 2 months ago |
Ultragenyx Pharmaceutical IncRARE | 7 | Strong Buy | $50.00 | +122.72% | Maintains | 4 months ago |
4d Molecular Therapeutics IncFDMT | 3 | Strong Buy | $33.00 | +248.10% | Maintains | 5 months ago |
Moderna IncMRNA | 10 | Hold | $25.00 | -49.19% | Maintains | 5 months ago |
Intellia Therapeutics IncNTLA | 9 | Strong Buy | $14.00 | +6.63% | Maintains | 5 months ago |
Sangamo Therapeutics IncSGMO | 5 | Hold | $1.00 | +233.33% | Downgrades | 5 months ago |
Ptc Therapeutics IncPTCT | 17 | Hold | $68.00 | +0.34% | Maintains | 5 months ago |
Sarepta Therapeutics IncSRPT | 16 | Hold | $20.00 | -13.90% | Maintains | 5 months ago |
Vertex Pharmaceuticals IncVRTX | 17 | Hold | $414.00 | -5.63% | Maintains | 5 months ago |
Solid Biosciences IncSLDB | 8 | Strong Buy | $9.00 | +20.16% | Maintains | 5 months ago |
Biocryst Pharmaceuticals IncBCRX | 11 | Hold | $9.00 | -0.22% | Maintains | 5 months ago |
Alnylam Pharmaceuticals IncALNY | 8 | Strong Buy | $527.00 | +65.28% | Maintains | 5 months ago |
Ionis Pharmaceuticals IncIONS | 11 | Strong Buy | $95.00 | +27.02% | Maintains | 5 months ago |
Biomarin Pharmaceutical IncBMRN | 6 | Strong Buy | $80.00 | +44.14% | Maintains | 5 months ago |
Cellectis SaCLLS | 4 | Strong Buy | $8.00 | +134.60% | Maintains | 6 months ago |
Kodiak Sciences IncKOD | 10 | Hold | $17.00 | -58.16% | Upgrades | 6 months ago |
Regenxbio IncRGNX | 7 | Strong Buy | $37.00 | +333.76% | Maintains | 8 months ago |
Avidity Biosciences IncRNAM | 4 | Strong Buy | $62.00 | +320.34% | Maintains | 8 months ago |
Crispr Therapeutics AgCRSP | 16 | Hold | $56.00 | +13.11% | Maintains | 8 months ago |
Beam Therapeutics IncBEAM | 10 | Hold | $21.00 | -14.84% | Maintains | 8 months ago |
Bluebird Bio IncBLUE | 10 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Vir Biotechnology IncVIR | 5 | Strong Buy | $31.00 | N/A | Maintains | a year ago |
Editas Medicine IncEDIT | 9 | Hold | $3.00 | N/A | Maintains | a year ago |
Mirati Therapeutics IncMRTX | 6 | Strong Buy | $71.00 | N/A | Maintains | 3 years ago |
Seagen IncSGEN | 3 | Hold | $228.00 | N/A | Maintains | 3 years ago |
Zymeworks IncZYME | 1 | Hold | $9.00 | N/A | Maintains | 3 years ago |
Arcturus Therapeutics Holdings IncARCT | 5 | Hold | $25.00 | N/A | Upgrades | 3 years ago |
Orchard Therapeutics PLCORTX | 2 | Strong Buy | $40.00 | N/A | Maintains | 4 years ago |
Meiragtx Holdings PLCMGTX | 1 | Strong Buy | $18.00 | N/A | Maintains | 4 years ago |
Tectonic Therapeutic IncTECX | 3 | Strong Buy | $48.00 | N/A | Maintains | 4 years ago |
Decibel Therapeutics IncDBTX | 2 | Strong Buy | $7.00 | N/A | Maintains | 4 years ago |
Sigilon Therapeutics IncSGTX | 1 | Strong Buy | $91.00 | N/A | Maintains | 4 years ago |
Logicbio Therapeutics IncLOGC2 | 1 | Strong Buy | $8.00 | N/A | Maintains | 4 years ago |
Axonics IncAXNX | 1 | Strong Buy | $79.00 | N/A | Maintains | 5 years ago |
Aceragen IncACGN | 1 | Hold | $2.00 | N/A | Downgrades | 5 years ago |
Eidos Therapeutics IncEIDX | 1 | Strong Sell | $45.00 | N/A | Downgrades | 6 years ago |
Tesaro IncTSRO | 1 | Hold | $75.00 | N/A | Downgrades | 7 years ago |
Puma Biotechnology IncPBYI | 5 | Strong Sell | $29.00 | N/A | Downgrades | 7 years ago |
Spark Therapeutics IncONCE | 4 | Strong Buy | $77.00 | N/A | Maintains | 8 years ago |
Avexis IncAVXS | 3 | Hold | N/A | N/A | Downgrades | 8 years ago |
Juno Therapeutics IncJUNO | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Cascadian Therapeutics IncCASC | 1 | Strong Sell | $4.00 | N/A | Initiates Coverage On | 9 years ago |
Abeona Therapeutics IncABEO | 1 | Strong Buy | $275.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.